Eleven amide and thioamide derivatives with monoterpene and adamantine substituents were synthesised. They were tested for their activity against the tyrosyl-DNA phosphodiesterase 1 DNA (Tdp1) repair enzyme with the most potent compound 47a, having an IC50 value of 0.64 M. When tested in the A-549 lung adenocarcinoma cell line, no or very limited cytotoxic effect was observed for the ligands. However, in conjunction with topotecan, a well-established Topoisomerase 1 (Top1) poison in clinical use against cancer, derivative 46a was very cytotoxic at 5 M concentration, displaying strong synergism. This effect was only seen for 46a (IC50—3.3 M) albeit some other ligands had better IC50 values. Molecular modelling into the catalytic site of Tdp1 predicted plausible binding mode of 46a, effectively blocking access to the catalytic site.
Background and Objective:
The DNA repair enzyme tyrosyl-DNA-phosphodiesterase 1 (TDP1) is a
current inhibition target to improve the efficacy of cancer chemotherapy. Previous studies showed that compounds
combining adamantane and monoterpenoid fragments are active against TDP1 enzyme. This investigation
is focused on the synthesis of monoterpenoid derived esters of 1-adamantane carboxylic acid as TDP1 inhibitors.
Methods:
New esters were synthesized by the interaction between 1-adamantane carboxylic acid chloride and
monoterpenoid alcohols. The esters were tested against TDP1 and its binding to the enzyme was modeling.
Results:
13 Novel ester-based TDP1 inhibitors were synthesized with yields of 21–94%; of these, nine esters
had not been previously described. A number of the esters were found to inhibit TDP1, with IC50 values ranging
from 0.86–4.08 µM. Molecular modelling against the TDP1 crystal structure showed a good fit of the active
esters in the catalytic pocket, explaining their potency. A non-toxic dose of ester, containing a 3,7-
dimethyloctanol fragment, was found to enhance the cytotoxic effect of topotecan, a clinically used anti-cancer
drug, against the human lung adenocarcinoma cell line A549.
Conclusion:
The esters synthesized were found to be active against TDP1 in the lower micromolar concentration
range, with these findings being corroborated by molecular modeling. Simultaneous action of the ester
synthesized from 3,7-dimethyloctanol-1 and topotecan revealed a synergistic effect.
Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is a promising target for anticancer therapy due to its ability to counter the effects topoisomerase 1 (Top1) poison, such as topotecan, thus, decreasing their efficacy. Compounds containing adamantane and monoterpenoid residues connected via 1,2,4-triazole or 1,3,4-thiadiazole linkers were synthesized and tested against Tdp1. All the derivatives exhibited inhibition at low micromolar or nanomolar concentrations with the most potent inhibitors having IC50 values in the 0.35–0.57 µM range. The cytotoxicity was determined in the HeLa, HCT-116 and SW837 cancer cell lines; moderate CC50 (µM) values were seen from the mid-teens to no effect at 100 µM. Furthermore, citral derivative 20c, α-pinene-derived compounds 20f, 20g and 25c, and the citronellic acid derivative 25b were found to have a sensitizing effect in conjunction with topotecan in the HeLa cervical cancer and colon adenocarcinoma HCT-116 cell lines. The ligands are predicted to bind in the catalytic pocket of Tdp1 and have favorable physicochemical properties for further development as a potential adjunct therapy with Top1 poisons.
Background:
Inhibition of the DNA repair enzyme, tyrosyl-DNA phosphodiesterase 1
(TDP1), may increase the efficacy of cancer drugs that cause damage to tumor cell DNA. Among
the known TDP1 inhibitors, there are compounds containing moieties of natural substances, e.g.,
monoterpenoids. In this work, we synthesized several compounds containing aromatic/
heteroaromatic amines and monoterpenoid groups and assessed their TDP1 inhibition potential.
Methods:
Structures of all the synthesized compounds were confirmed by 1H and 13C NMR as well
as HRMS. The TDP1 inhibitory activity of the amines was determined by real-time fluorescence
oligonucleotide biosensor.
Results:
The synthesized secondary amines had TDP1 inhibitory activity IC50 in the range of
0.79-9.2 µM. The highest activity was found for (–)-myrtenal derivatives containing p-bromoaniline
or m-(trifluoromethyl)aniline residue.
Conclusion:
We synthesized 22 secondary amines; of these, 17 amines are novel chemical structures.
Many of the amines inhibit TDP1 activity in the low micromolar range. Therefore, these
compounds are promising for further study of their antiproliferative activity in conjunction with
DNA damaging drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.